James S Goydos MD
Surgical Oncology (Other than Breast)
American Association for Cancer Research (AACR); Clinical Cancer Research Journal
Join to View Full Profile
195 Little Albany StNew Brunswick, NJ 08901
Phone+1 732-235-2465
Dr. Goydos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James S. Goydos is a general surgeon in New Brunswick, New Jersey and is affiliated with multiple hospitals in the area. He has been in practice for more than 20 years.
Clinical Expertise
- Skin cancer, Melanoma, Soft tissue cancer, Soft tissue sarcomas, Oncology, Surgical oncology (non-breast), Merkel cell carcinoma, Skin cancer surgery, Health education, Biochemistry
Education & Training
University of ConnecticutResidency, Surgery, 1988 - 1993
Rutgers Robert Wood Johnson Medical SchoolClass of 1988
Certifications & Licensure
NJ State Medical License 1995 - 2021
Awards, Honors, & Recognition
- ACS Fellow
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Join now to see all
Clinical Trials
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery Start of enrollment: 2007 Feb 01
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 13 citationsRandomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with me...Elliot J. Coups, Sharon L. Manne, Pamela Ohman Strickland, Michelle Hilgart, James S. Goydos
Contemporary Clinical Trials. 2019-06-27 - 45 citationsParticipation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo.Seung-Shick Shin, Byeong-Seon Jeong, Brian A. Wall, Jiadong Li, Naing Lin Shan
Oncogenesis. 2018-11-14 - 34 citationsA phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.Janice M. Mehnert, Ann W. Silk, Jonathan H. Lee, Liesel Dudek, Byeong-Seon Jeong
Pigment Cell & Melanoma Research. 2018-07-01
Lectures
- Melanoma & Skin Cancer Patient & Caregiver SymposiumCancer Institute Of New Jersey Cinj - 5/16/2017
- Treatment of Locally and Regionally Advanced MelanomaRutgers Cancer Institute of New Jersey - 9/13/2014
Other
- Methods and Compositions for Treating Cancer; PatentJames S. Goydos, Suzie Chen, Current Assignee: Rutgers State University of New Jersey
https://patents.google.com/patent/US20100221246A1/en?inventor=James+S.+Goydos
4/6/2010 - Methods and Compositions for Treating Melanoma; PatentJames S. Goydos, Suzie Chen, Current Assignee: Rutgers State University of New Jersey
https://patents.google.com/patent/US7691377B2/en?inventor=James+S.+Goydos
4/6/2010 - Detection of Mutations in Nucleic Acid Sequences; PatentJames S. Goydos, Application filed by University Of Medicine And Dentistry Of New Jersey
https://patents.google.com/patent/WO2005006940A2/en?inventor=James+S.+Goydos
6/30/2005
Authored Content
- Can You Get a Sunburn in the Winter?December 2021
- Can You Get a Sunburn in the Winter?December 2021
- When Do Americans Get Their Freedom BackNovember 2021
- Melanoma Knows No SeasonNovember 2021
- The Importance of Breast Cancer AwarenessOctober 2021
- Rates of Skin Cancer in New Jersey Higher Than the National AverageSeptember 2021
- How Both The Mentor And The Mentee Help Each Other SucceedAugust 2021
- Humans Are Never Far From Chaos And BarbarismAugust 2021
- Everyday Ways to Give Back to the CommunityJuly 2021
- Any Competent Public Health Doctor Could Predict What Would Happen During The PandemicMay 2021
- Any Competent Public Health Doctor Could Predict What Would Happen During The PandemicMay 2021
- How a Trauma Death Can Turn Doctors into Better SurgeonsMay 2021
- How a Trauma Death Can Turn Doctors into Better SurgeonsMay 2021
- What Ever Happened to the Concept of the Absent-Minded Professor?April 2021
- What Ever Happened to the Concept of the Absent-Minded Professor?April 2021
- The Trolley Problem & The Pandemic: What Would You Choose?January 2021
- What You May Not Know About Breast CancerOctober 2020
- Coronavirus and Physician Burnout Are Adding Fuel to the FireOctober 2020
- Why ‘White Coat Syndrome’ and The Pandemic Are A Double ThreatOctober 2020
- Why Do We Still Use Fax Machines In Medicine?October 2020
- Join now to see all
Press Mentions
On Memorial Day, We Should Talk Skin Cancer in the MilitaryMay 28th, 2022- When Do Americans Get Their Freedom Back?September 14th, 2021
Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer InstituteMay 18th, 2020- Join now to see all
Grant Support
- Regulation of tumor released exosomes and glutamatergic signalingNational Cancer Institute2014–2017
- Combination Therapy that Targets Glutamate Signaling in MelanomaNational Cancer Institute2010–2015
- A Patient Oriented Research Program for Surgical OncologistsNational Cancer Institute2010–2015
- Validation of Grm1 as a Therapeutic Target in MelanomaNational Cancer Institute2007–2013
- A Phase II Trial of Riluzole in Patients with Advanced MelanomaNational Cancer Institute2009–2011
- A Phase 0 Trial of Riluzole in Patients with Resectable Stage III or IV MelanomaNational Cancer Institute2007–2008
Professional Memberships
- Editorial Board Member
Other Languages
- Spanish
External Links
- Publicationshttps://orcid.org/0000-0001-9811-939X
- LinkedInhttp://www.linkedin.com/in/jamesgoydos
- Websitehttps://www.jamesgoydos.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
